Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07600814
EARLY_PHASE1

Pain Induced by m-Cresol as Preservative

Sponsor: Medical University of Vienna

View on ClinicalTrials.gov

Summary

Preservatives such as m-Cresol are essential components in many subcutaneously injected medications, including insulin or human growth hormone, to prevent bacterial growth. However, clinical reports have suggested that these preservatives may cause local discomfort or pain at the injection site, which can negatively impact treatment adherence. While m-Cresol is widely used, its direct contribution to injection-site pain has not yet been investigated in a prospective clinical trial. This study aims to investigate whether subcutaneous injection of m-Cresol at concentrations commonly used in clinical practice (0.1% and 0.25%) cause significantly more pain than a preservative-free control solution. In a randomized, double-blind crossover design, healthy volunteers will receive three separate injections in a belly fold. Participants will rate their pain every 5 seconds until it subsides. The findings will help determine if m-Cresol is a primary source of injection-site pain and could lead to the development of more comfortable drug formulations.

Official title: Pain Induced by m-Cresol as Preservative - A Randomised Controlled Crossover-Trial in Healthy Volunteers

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

18

Start Date

2026-05-25

Completion Date

2026-06-08

Last Updated

2026-05-22

Healthy Volunteers

Yes

Interventions

OTHER

m-Cresol 0.1%

A preservative administered subcutaneously at 0.1%, a common concentration used in medicines.

OTHER

m-Cresol 0.25%

A preservative administered subcutaneously at 0.25%, a common concentration used in medicines.

OTHER

Control Solution

A control solution administered subcutaneously.